CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 16 February 2016 |
| Author/s |
author: Eiji Sugihara Hideyuki Saya |
| Publication date | March 28, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |